FDA Opens Door to Quicker Approval of Osteoporosis Drugs

(MedPage Today) — The FDA gave the greenlight to use total hip bone mineral density (BMD) as a validated surrogate endpoint for clinical osteoporosis drug trials, the FDA announced on Friday.
A BMD test measures calcium and other bone minerals…